Nadège Joly

BioFIT team will be in Lyon (France) to attend BioVision on April 13th & 14th.

BioVision is an annual meeting, which brings together international decision makers and innovation holders from the academic, private, policy-making and civil society sectors to debate, find partnerships and invest.

Beyond the foresight, BioVision‘s ambition is to facilitate collaboration between different actors, innovation and ultimately access to knowledge and solutions for the general public.

Take advantage of that perfect opening to get an extensive overview of BioFIT activities, or just have a chat with our team 😉 !

The 3 activities of the BioFIT Presentation Sessions give young entrepreneurs, researchers and tech transfer professionals the opportunity to present their projects and find partners who share their vision.

• Are you already or thinking about creating an innovative academic spin-off company and do you have a business plan to present?

Please apply for the Business Plan Slams and get the opportunity to present your business plan, raise awareness among pharmas, biotechs, TTOs, investors and media, and in addition receive valuable feedback and advices from an expert jury

---

Please apply for the Licensing Opportunities Presentations and get the opportunity to present your technology and raise awareness among pharmas, biotechs, TTOs, investors and media.

The BioFIT Licensing Opportunities Presentations are organised in partnership with TechnoMarket

BioFIT team and NHL Cluster will be in Stockholm (Sweden) to attend

BIO-Europe Spring on March 4^th to 6^th.

BIO-Europe Spring continues this year the tradition of providing life science companies with high caliber partnering opportunities.That is everything needed to enable delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, but most of all, a perfect occasion to come and meet us !

Take advantage of that perfect opening to get an extensive overview of BioFIT activities,or just have a chat with our team 😉 !

BioFIT team will be pleased to attend Forum LABO & BIOTECH

on March 30th & 31th in Lyon, France

The Forum LABO & BIOTECH is the exhibition of laboratory materials and services suppliers. This event gathers researchers, engineers, scientists, buyers, and decision makers in all sectors (academic research, R&D, analysis and testing in agri-foods, the environment, chemicals, pharmaceuticals, biotechnology, healthcare, energy…)

With around 150 exhibitors, Forum LABO & BIOTECH is the right place to identify new partners but it’s also the perfect occasion to come and meet us! Take advantage of that perfect opening to get an extensive overview of BioFIT activities, or just have a chat with our team 😉

Roche signs a €900M deal with Blueprint Medicines

Roche (Switzerland), leader in cancer therapies, has been redirecting its efforts towards immuno-oncology and has picked 5 candidates from Blueprint Medicines (Boston, US) to complement its leading oncology pipeline.
Blueprint Medicines will receive €40M upfront to collaborate on the development of 5 of its preclinical candidates. Depending on how these small molecule therapies perform in trials, Blueprint could be aiming at over €850M in milestones and licenses.

Source : La Biotech.eu 

AstraZeneca and Genentech put pen on paper and bankroll to finance PatientsLikeMe study on lung cancer

AstraZeneca and Genentech (a member of the Roche Group) have agreed to finance a study of lung cancer patients that will analyze PatientsLikeMe’s patient-reported outcomes alongside traditional forms of data. The project is designed to assess the value of giving researchers a broader overview of factors that can affect health outcomes.

Source : FierceBiotechIT

Cellectis and MabQuest announce immunotherapy partnership

Cellectis (France) and MabQuest announced that they have entered into a research collaboration and license agreement pertaining to the development of a new class of monoclonal antibodies targeting PD-1. These anti-PD-1 mAbs have potential uses for multiple indications in immunotherapy, including notably treatments for a variety of cancers.

Source : BusinessWire

Johnson & Johnson Innovation launches JLINX: A new company incubation model 

Located at the Janssen Campus in Belgium, JLINX will offer scientists and entrepreneurs access to venture funding, state-of-the-art facilities and R&D expertise. JLINX is designed to accelerate early-stage transformative innovation, including an emphasis on the human microbiome as well as broader life-science research.

Source : BusinessWire

We are honored to count among our Supporters for BioFIT 2016: Asebio, Atlanpole Biotherapies, BIA, Biocat, Bionow, BioPartner, Danish Diabetes Academy, Innoget, MediWales, One Nucleus…

Discover the 2016 Supporters here.

As these organizations, become a Supporter of BioFIT and:

• Increase your visibility among 1,300 Life Sciences leading actors
• Get a free pass to attend the event
• Offer your members an incredible 25% discount to attend the event
• …

Contact us to discover all the other benefits!

It’s time to sign up!

Early Bird

The arrival of spring season reminds us that the Early Bird is still running! It’s now time to sign up and benefit from 20% off on BioFIT regular registration fees.

Register now and enjoy the Early Bird offer!

Boost your visibility

With a limited number of stands, do not miss the opportunity to enhance your visibility at an international scale and get identified as a key innovative actor in Life Sciences.

Book your booth now and benefit from the best location in BioFIT exhibition area!

The Pharma Logistics Club organises a lunch-debate on March 15th (Cité des Echanges in Marcq-en-Baroeul) around logistics issues of health products.

During this lunch debate, Etienne Vervaecke, Eurasanté, Nicolas De Clerck, Club logistique et transport
Pascale Percherin, LFB will present their organisations and share their experience with the participants.

This conference will also be an opportunity to present BioFIT to this new audience.

The Pharma Logistics Club (PLC) is a professional association with 50 members including a dozen of health institutions. Its purpose is to facilitate relationships between professionals in the supply chain, laboratories, freight forwarders… in the health sector. PLC organises lunch debates, site visits, working committees and regular meetings to allow to cross its audiences.

We are honored to count among our Media Partners for BioFIT 2016: Actulabo, GIT Laboratory Journal Europe, Global Data, Innovation Review, Iptechex, La Gazette du Laboratoire…

Like them, become a Media Partner of BioFIT and:

• Increase your visibility among 1,300 Life Sciences leading actors
• Get a free pass to attend the event
• Benefit from the opportunity to have your magazine displayed during the event
• Schedule interviews with the Steering Committee Members and/or the participants

You are a media specialized in Life Sciences, Biotechnology or Pharmaceutical Industry?

Contact us to become a Media Partner

We were pleased to welcome Philips during this Meeting Day organized by Eurasanté.

This Philips meeting day was an opportunity to discover Philips activities and the company’s collaboration strategy.

B to B meetings with Philips representatives were scheduled and discussions were also held between Philips, industrial stakeholders and researchers around potential partnerships.

Hope you enjoyed this moment and had fruitful meetings!